Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.21
-3.43 (-1.63%)
AAPL  271.97
-2.26 (-0.82%)
AMD  202.34
-8.52 (-4.04%)
BAC  51.83
+0.14 (0.27%)
GOOG  305.89
-7.14 (-2.28%)
META  654.08
+0.39 (0.06%)
MSFT  400.26
-0.34 (-0.08%)
NVDA  187.22
-8.34 (-4.26%)
ORCL  146.24
-1.65 (-1.12%)
TSLA  404.95
-12.44 (-2.98%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.